Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0002018150-25-000003

Options or other derivatives

  • Chief Science Officer Virology acquired 32,406 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pauza Charles David · Chief Science Officer Virology

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-12 Grant or award : show line 1 in the form Stock Option (right to purchase) +32,406 32,406 D
Loading xslF345X05/form4-10162025_121042.xml…